{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-020491","form_type":"8-K","ticker":"TGTX","cik":"0001001316","company_name":"TG THERAPEUTICS, INC.","filed_at":"2026-06-12T20:32:23+00:00","discovered_at":"2026-06-12T20:33:00.721075+00:00","generated_at":"2026-06-12T20:53:35.895811+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.15,"confidence":"high","headline":"TG Therapeutics say-on-pay fails at 2026 annual meeting; directors elected","bullets":["Proposal 3 (say-on-pay): 48.9M votes against vs 31.9M in favor; not approved.","All six director nominees elected; Sagar Lonial received 54.85% support, lowest.","Ratification of KPMG as auditor approved: 112.3M for, 531.8K against.","Quorum of 113.0M shares (73.81% of outstanding) present at June 11 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-020491","json":"https://secwatch.observer/filing/0001437749-26-020491.json","markdown":"https://secwatch.observer/filing/0001437749-26-020491.md","text":"https://secwatch.observer/filing/0001437749-26-020491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/tgtx20260612_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:53:35.895811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"284297851b1054dec01fd22237310652d3a95a75","claim":"TG THERAPEUTICS, INC. shareholders approved Election of six directors to hold office until the 2027 annual meeting at the 2026-06-11 meeting.","evidence_excerpt":"Proposal 1 The votes with respect to the election of the six directors to hold office until the 2027 annual meeting were as follows: Director Votes For % Voted For Votes Withheld % Voted Withheld Broker Non-Votes Michael S. Weiss 72,172,630 88.63% 9,260,279 11.37% 31,570,505 Laurence N. Charney 68,135,448 83.67% 13,297,461 16.33% 31,570,505 Yann Echelard 64,110,661 78.73% 17,322,248 21.27% 31,570,505 Kenneth Hoberman 53,354,717 65.52% 28,078,192 34.48% 31,570,505 Daniel Hume 63,979,535 78.57% 17,453,374 21.43% 31,570,505 Sagar Lonial, MD 44,666,544 54.85% 36,766,365 45.15% 31,570,505","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"522ac5230b8f2f8d4381306454be285ad9ca4b41","claim":"TG THERAPEUTICS, INC. shareholders rejected Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-11 meeting.","evidence_excerpt":"Proposal 3 The advisory vote to approve the compensation of the Company’s named executive officers was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 31,905,837 48,858,169 668,903 31,570,505","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"ee310ebe993a8dd40b1d8d333a3d563f7a67ac82","claim":"TG THERAPEUTICS, INC. shareholders approved Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.","evidence_excerpt":"Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 112,329,330 531,758 142,326 --","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}